Benitec Biopharma Inc. (BNTC) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 |
|---|
| Cash from Operations | -4.91M | -3.78M | -3.35M | -8.53M | -3.09M | -7.7M | -4.59M | -3.29M | -6.24M | -5.33M | -4.58M | -3.84M | -4.03M | -5.65M | -4.04M | -4.72M | -3.42M | -3.34M | -4.28M | -5.16M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | -54804.23% | -7461.11% | -40368.53% | - | - | -7129.17% | -13376% | - | -257850% |
| Operating CF Growth % | -59.16% | 50.98% | 26.93% | -158.99% | 50.53% | -44.43% | -0.2% | 14.16% | -54.82% | 5.63% | -13.15% | 18.67% | -17.74% | -69.01% | 5.45% | 8.53% | -72.05% | -0.54% | -81.27% | -63.97% |
| Net Income | -11.94M | -11.84M | -8.96M | -8.8M | -9.35M | -7.36M | -5.06M | -4.72M | -4.28M | -6.8M | -5.95M | -4.66M | -4.4M | -5.41M | -5.09M | -5.07M | -3.27M | -4.82M | -5.04M | -4M |
| Depreciation & Amortization | 119K | 120K | 118K | 118K | 106K | 81K | 91K | 91K | 90K | 80K | 82K | 84K | 93K | 41K | 102K | 63K | 114K | 113K | 102K | 102K |
| Stock-Based Compensation | 0 | 7.38M | 5.18M | 0 | 2.6M | 943K | 435K | 454K | 192K | 0 | 91K | 0 | 71K | 0 | 302K | 0 | 192K | 239K | 271K | 279K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.2M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 7.11M | 701.01K | 125.21K | 5.66M | 2.91M | -764K | 0 | -5.8K | -78.2K | 133.31K | 1.2M | 393.12K | 4K | 210.46K | -3K | 311.12K | 5K | 23K | -18K | -19K |
| Working Capital Changes | -203.06K | -139.01K | 190.79K | -5.5M | 659K | -606K | -53K | 887.8K | -2.16M | 1.25M | 1.2M | 347.58K | 200K | -492.06K | 647K | -24.23K | -459K | 1.1M | 412K | -1.52M |
| Change in Receivables | -122.05K | 123.01K | 29.97K | -22.85K | 0 | 0 | 226K | 0 | 0 | 0 | 0 | 826 | 0 | 0 | 0 | -45.49K | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 449.6K | 0 | 0 | -5.11M | 0 | 0 | -322K | 1.55M | -2.31M | 1.14M | 566K | 761.96K | 0 | -549.03K | 500K | 565.79K | 0 | 0 | 0 | 0 |
| Cash from Investing | -16.04K | -11K | 0 | -466 | -6K | -12K | 0 | -565 | -179.42K | 0 | 0 | -993 | 0 | 0 | 0 | -12.79K | 0 | 0 | 0 | 141K |
| Capital Expenditures | -16.04K | -11K | 0 | -466 | -18K | -12K | 0 | -565 | -179.42K | 0 | 0 | -993 | 0 | 0 | 0 | -12.79K | 0 | 0 | 0 | 141K |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | 14.19% | - | 40368.53% | - | - | - | - | - | 7050% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 12K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 4.36M | 98.23M | 0 | 4.28M | 28.41M | 17.87M | 21.66M | 40.07M | 154.88K | -49.6K | 27.92M | -264.58K | 0 | -310.01K | 16.02M | 0 | 0 | 0 | 0 | 12.67M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 4.36M | 98.41M | 0 | 4.28M | 26.49M | 17.87M | 21.66M | 43M | 154.88K | -49.6K | 30.88M | -264.58K | 0 | -310.01K | 17.88M | 0 | 0 | 0 | 0 | 14.25M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | -178.7K | 0 | 0 | 1.92M | -2K | 0 | -2.93M | 0 | 0 | -2.96M | 0 | 0 | 0 | -1.87M | 0 | 0 | 0 | 0 | -1.58M |
| Net Change in Cash | -4.03M | 94.31M | -3.27M | -5.79M | 25.3M | 10.44M | 16.98M | 36.77M | -6.23M | -5.49M | 23.39M | -4.08M | -3.99M | -6M | 12.47M | -4.55M | -3.7M | -3.4M | -4.04M | 7.78M |
| Free Cash Flow | -4.93M | -3.79M | -3.35M | -8.53M | -3.09M | -7.71M | -4.59M | -3.29M | -6.42M | -5.33M | -4.58M | -3.84M | -4.03M | 0 | -4.04M | -4.73M | -3.42M | -3.34M | -4.28M | -5.02M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | -54818.43% | -7461.11% | - | - | - | -7129.17% | -13376% | - | -250800% |
| FCF Growth % | -59.37% | 50.91% | 26.93% | -159.01% | 51.82% | -44.65% | -0.2% | 14.18% | -59.27% | - | -13.15% | 18.87% | -17.74% | 100% | 5.45% | 5.7% | -70.76% | 4.46% | -68.89% | -58.83% |
| FCF per Share | -0.10 | -0.08 | -0.08 | -0.24 | -0.08 | -0.35 | -0.43 | -0.33 | -0.61 | -0.52 | -0.53 | -0.58 | -2.45 | - | -1.58 | -2.46 | -1.78 | -1.74 | -2.22 | -3.02 |
| FCF Conversion (FCF/Net Income) | 0.41x | 0.32x | 0.37x | 0.53x | 0.21x | 0.81x | 0.91x | 0.70x | 1.46x | 0.78x | 0.77x | 0.82x | 0.92x | 1.04x | 0.79x | 0.93x | 1.04x | 0.69x | 0.85x | 1.29x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |